The studies linking this gene to EBV-positive B-cell lymphoma have both been relatively small and have examined a disparate collection of classical HL and non-HL, non-BL, making it difficult to draw conclusions on the role of FCGR2A in EBV susceptibility and disease [78,80]. The gene discussed is FCGR2A; the disease is B-cell non-Hodgkin lymphoma.